Posts and Stories
-
Reverba Completes Acquisition of Six Degrees Worldwide to Unite Science and the Patient Voice to Advance Healthcare
SEATTLE, WA – Reverba, renowned for its innovative patient engagement solutions for biopharmaceutical companies, today announced the acquisition of Six Degrees Worldwide Inc., a leader in medical communications within the same…
-
HBA Rising Star: Crystal Anderson
By: Cheryl Lubbert We’re thrilled to announce the Healthcare Businesswomen’s Association (HBA) recently named Crystal Anderson, MPH, VP, Client Partner Lead as one of its 2024 Rising Stars. Crystal joins…
-
Treatments for All: The Importance of Diversity in Clinical Trial Enrollment
By: Scott Lerman, VP, Partnerships Lead We start, as many stories do, with a personal anecdote. I love this photo. It’s of my grandmother and my father, taken at my…
-
“The secret to successful patient influencer marketing? Authenticity”
Published in pharmaphorum By: Cheryl Lubbert, Co-Founder and CEO Reverba It may not be as straightforward as it is in the realms of fast fashion or tourism, but influencer marketing,…
-
Reverba CEO and Co-Founder Cheryl Lubbert Wins 2023 Silver Stevie® Award for Women in Business
– Awards recognize female entrepreneurs, executives and employees who are making positive contributions to their workplace and to the greater community – SEATTLE, WA, Nov. 13, 2023 – Reverba, a leading global…
-
Survey: 3 Surprising Things BioPharma Can Learn about Patients’ Perceptions
By Jean McCoy Reverba EVP, Partnerships Perception is reality, as the saying goes. But sometimes, we can be too entrenched in our daily routine, entrenched in our field, and we…
-
Authenticity In An Automated World: Surprising Guidance From Healthcare
Published in Forbes By: Cheryl Lubbert, Forbes Councils Member When faced with online customer service “agents” who don’t have real answers or solutions for specific problems, email responses that don’t…
-
Embrace the Rainbow: Three Tips to Make DEI Foundational In Your Clinical Program
By: Jean McCoy Diversity in clinical trials is a hot-button topic, with attention and programs ranging from legislation (both proposed and passed) to industry conference panels and required continuing education…
-
The Patient Voice: Industry and Advocates Speak in Harmony
By: Jean McCoy A generation ago, HIV/AIDS patients had to “Act Up” to be heard. A recent virtual summit shows how much has changed since the days of that pioneering…
-
How Can We Have More Successful Rare Disease Trials?
By: Reverba Clinical Partnerships Team More than 300 million people around the world live with a rare disease—that is, a condition that affects fewer than 1 in 2,000. Although each…
-
Patient insights on trials: improving trust, the experience, and diversity.
By: Reverba Clinical Partnerships Team We have all made New Year’s resolutions – some we keep, and some never come to fruition. What are your goals as an organization? You…
-
Patient Engagement: What Matters Most in 2023. A retrospective by Cheryl Lubbert
By: Cheryl Lubbert Think about 2022 – what stands out to you the most? For me, it’s how often we heard that things were “returning to normal” after two years…